Pharmacokinetic, Safety and Immunogenicity Study of CMAB015 and Cosentyx in Healthy Volunteers
Clinical trial NCT05734482 · COMPLETED
Trial details
- NCT number
- NCT05734482
- Sponsor
- Taizhou Mabtech Pharmaceutical Co.,Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-15
- Primary completion
- 2023-07-03
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.